Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 151 - 180 of 373
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Sitagliptin - Metformin Zentiva ApS 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2024-07-12
		European Medicines Agency's website: Sitagliptin Accord - EMA: EPAR PI Finnish Swedish
PL	Resepti	Sitagliptin Glenmark 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2021-08-17
PL	Resepti	Sitagliptin Grindeks 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-02-10
PL	Resepti	Sitagliptin Hexal 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-03-15
PL	Resepti	Sitagliptin Krka 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2024-04-19
PL	Resepti	Sitagliptin Orion 25 mg, 50 mg, 100 mg, tabletti, kalvopäällysteinen SPC 2020-12-02
PL	Resepti	Sitagliptin ratiopharm 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2023-01-13
PL	Resepti	Sitagliptin Sandoz 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-10-31
PL	Resepti	Sitagliptin STADA 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-07-19
		European Medicines Agency's website: Sitagliptin SUN - EMA: EPAR PI Finnish Swedish
PL	Resepti	Sitagliptin Viatris 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2024-05-28
PL	Resepti	Sitagliptin Zentiva 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2021-12-17
PL	Resepti	Sitagliptin Zentiva ApS 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2024-10-16
PL	Resepti	Sitagliptin-Metformin Glenmark 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2024-06-19
PL	Resepti	Sitagliptin-Metformin Grindeks 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2024-11-19
PL	Resepti	Sitagliptin-Metformin Hexal 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-09-14
PL	Resepti	Sitagliptin-Metformin Krka 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2023-12-12
PL	Resepti	Sitagliptin-Metformin Orion 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2023-09-15
PL	Resepti	Sitagliptin-Metformin Pharmathen 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2024-04-24
PL	Resepti	Sitagliptin-Metformin ratiopharm 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2024-07-09
PL	Resepti	Sitagliptin-Metformin Reddy 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2024-02-06
PL	Resepti	Sitagliptin-Metformin Sandoz 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-03-14
PL	Resepti	Sitagliptin-Metformin STADA 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2024-06-19
PL	Resepti	Sitagliptin-Metformin Zentiva 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2024-07-30
		European Medicines Agency's website: Sitagliptin/Metformin Hydrochloride Accord - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Sitagliptin/Metformin hydrochloride Mylan - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Sitagliptin/Metformin hydrochloride SUN - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Sivextro - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Sixmo - EMA: EPAR PI Finnish Swedish
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >